Education
About Us
Working with TipRanks
Follow Us
Neal Flomenberg Insider Profile
4 Followers
Neal Flomenberg, Chief Scientific Officer, Global R&D Lead at Tevogen Bio Holdings, holds 3.90M shares in Tevogen Bio Holdings (Ticker: TVGN).
Neal Flomenberg Tevogen Bio Holdings (TVGN)Chief Scientific Officer, Global R&D Lead
Tevogen Bio Holdings (TVGN)
Chief Scientific Officer, Global R&D Lead
Ranked #22,321 out of 102,830 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+18.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Neal Flomenberg's holdings
Insider Roles
Chief Scientific Officer, Global R&D Lead
Roles that Neal Flomenberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Neal Flomenberg
Neal Flomenberg's Trading History
List of latest transactions for each holding click on a transaction to see Neal Flomenberg's performance on stock
You May Also Like
Neal Flomenberg insider profile FAQ
What is the percentage of profitable transactions made by Neal Flomenberg?
The percentage of profitable transactions made by Neal Flomenberg is 100%.
What is the average return per transaction made by Neal Flomenberg?
The average return per transaction made by Neal Flomenberg is 18.00%.
What stocks does Neal Flomenberg hold?
Neal Flomenberg holds: TVGN stocks.
What was Neal Flomenberg’s latest transaction?
Neal Flomenberg latest transaction was an Uninformative Buy of ―.
What was Neal Flomenberg's most profitable transaction?
Neal Flomenberg’s most profitable transaction was an Informative Sell of TVGN stock on October 18, 2024. The return on the trade was 41.90%.
What is Neal Flomenberg's role in Tevogen Bio Holdings?
Neal Flomenberg's role in Tevogen Bio Holdings is Chief Scientific Officer, Global R&D Lead.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.